Archive for December, 2012

« Previous Entries

Endurance Training makes Aging Less Problematic

Monday, December 31st, 2012

Endurance exercises like running and other track-based exercises may prevent certain effects of aging from occurring in individuals, according to a recent study by Javaid Nauman, PhD, and other colleagues from the Norwegian University of Science and Technology, Trondheim. The study was conducted on telomeres, which are chromosome caps that including noncoding and repetitive DNA […]

The Fiscal Cliff May Trigger Medicare Cuts

Sunday, December 30th, 2012

The fiscal cliff is looming ahead, but the Congress and White House are still locked in a stalemate over striking a deal to solve the problem. As a result, doctors and medical professionals are bracing for a 28.5 percent Medicare payment cut that will automatically take effect on January 1, 2013. This includes a 26.5 […]

Meningitis Outbreak Still Prevalent

Saturday, December 29th, 2012

During fall of 2012, a fungal meningitis outbreak was reported, and it is still prevalent even today as per the latest reports. It was an unprecedented event when it began, but according to Tom Chiller, deputy director of the Mycotic disease branch of the CDC, it is not over yet. The size and spectrum of […]

New Drug for Stroke Prevention

Friday, December 28th, 2012

Eliquis (generic name: apixaban) has received approval from the FDA after the drug received similar approvals by the regulatory bodies in Canada, Japan, and Europe. The medicine is an oral anticoagulant indicated for systemic embolism and stroke prevention among patients diagnosed with non-valvular atrial fibrillation. The safety and efficacy of apixaban for the indicated conditions […]

EHRs Not Alone in Higher ED Care Bills

Thursday, December 27th, 2012

It has been a common perception that the greater use of electronic healthy records (EHRs) has contributed to an increase in the expense of procedures conducted by emergency department (ED) physicians. This is because emergency departments are now able to use EHRs to capture the procedures in greater detail and add more charges for them. […]

New Medicine for Rare Lipid Disorder

Wednesday, December 26th, 2012

The FDA recently approved lomitapide, a lipid-lowering drug that will be given as supplementary therapy for patients suffering from a rare lipid disorder. The drug, which will have the brand name Juxtapid, is intended for patients suffering from homozygous familial hypercholesterolemia or HoFH. It reduces the amount of total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein […]

A New Drug for Acute Heart Failure

Tuesday, December 25th, 2012

A recent analysis of data collected through the RELAX-AHF trial has shown that seralaxin, a new blood vessel relaxer, may reduce mortality associated with acute heart failure by speeding up decongestion and reducing organ damage. The trial’s safety results showed that the risk of cardiovascular death and all-cause mortality had reduced by 37 percent in […]

Increased Mortality Risk during Transfusion after MI

Monday, December 24th, 2012

A blood transfusion conducted after a myocardial infarction (MI) increased the mortality risk two folds and also increased the chances of another MI in survivors, according to a meta-analysis conducted recently. The analysis of several related studies reported that around 18 percent of patients that got a blood transfusion died as compared to the 10 […]

Reduced Atherosclerosis Cases among Soldiers

Sunday, December 23rd, 2012

The number of atherosclerosis cases among combat casualties has reduced by a large amount since the Vietnam and Korean wars, according to a recent study. Among the 4,000 young soldiers who died in action at the Persian Gulf over the decade, only 8.5 percent had coronary atherosclerosis. The study was conducted by the Uniformed Services […]

Early CPAP Not So Effective for Extreme Premature Babies

Saturday, December 22nd, 2012

A long-term SUPPORT trial of randomized cases affirmed that early continuous positive airway pressure (CPAP) has little improvement in store for extremely premature infants when compared to surfactant treatment. In fact, it may also worsen the outcome in some cases. The death rate of babies before neurodevelopmental impairment or 18-22 months was almost the same […]

« Previous Entries